Quarterly ResultAug 5, 2026, 05:04 PM
Evolus Q2 Revenue +21.2% to $84.1M; Net Loss Narrows to $8.1M
AI Summary
Evolus, Inc. reported a significant improvement in its second-quarter 2026 financial results, with total net revenues increasing by 21.2% to $84.1 million and net loss narrowing to $8.1 million from $17.1 million in the prior year. For the first six months of 2026, net revenues grew 14.0% to $157.2 million, and net loss decreased to $18.7 million from $36.0 million. The company also launched four Evolysse® products in Europe and secured a new $30 million revolving credit facility.
Key Highlights
- Total net revenues for Q2 2026 increased 21.2% to $84.08 million.
- Net loss for Q2 2026 narrowed to $8.05 million from $17.14 million in Q2 2025.
- Net loss per share for Q2 2026 was $(0.12), an improvement from $(0.27) in Q2 2025.
- Launched four Evolysse® products in Europe in May 2026.
- Entered a new $30 million Revolving Credit Facility in March 2026.
- Net cash used in operating activities for YTD 2026 was $(13.54) million, down from $(40.42) million.
- Recorded a $1.95 million tariff refund receivable as of June 30, 2026.
Price Impact
More from EOLS